Zhou D, Gu FM, Gao Q, Li QL, Zhou J, Miao CH. Effects of anesthetic methods on preserving anti-tumor T-helper polarization following hepatectomy. World J Gastroenterol 2012; 18(24): 3089-3098 [PMID: 22791944 DOI: 10.3748/wjg.v18.i24.3089]
Corresponding Author of This Article
Dr. Chang-Hong Miao, MD, PhD, Department of Anesthesiology, Fudan University Shanghai Cancer Center, Shanghai 200032, China. miaochh@yahoo.com.cn
Article-Type of This Article
Original Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 2 T-helper 1, T-helper 2, T-helper 17 and regulatory T cell frequencies in patients
Variables
d0 (%)
d2 (%)
d7 (%)
P (d0/d2)
P (d0/d7)
P (d2/d7)
Th1
7.21 ± 1.01
18.82 ± 1.93
13.40 ± 0.79
< 0.001
< 0.001
0.015
Th2
1.12 ± 0.09
3.32 ± 0.31
0.93 ± 0.10
< 0.001
0.180
< 0.001
Th17
2.57 ± 0.22
2.95 ± 0.26
1.23 ± 0.10
0.269
< 0.001
< 0.001
Treg
6.02 ± 0.27
6.93 ± 0.38
5.45 ± 0.52
0.160
0.329
0.021
Th1/Th2
8.12 ± 1.24
8.50 ± 1.14
14.87 ± 1.26
0.823
< 0.001
< 0.001
Table 3 Comparison of T-helper 1, T-helper 2, T-helper 17, regulatory T cell frequencies and T-helper 1/T-helper 2 cell ratio between G + E and G anesthesia groups
Variables
G + E group (%)
G group (%)
P
Th1
d0
7.44 ± 1.54
7.38 ± 1.35
0.87
d2
14.66 ± 1.96
20.42 ± 2.77
0.098
d7
16.57 ± 0.96
10.37 ± 0.84
< 0.001
Th2
d0
1.08 ± 0.14
1.14 ± 0.12
0.745
d2
2.64 ± 0.30
3.98 ± 0.49
0.028
d7
0.73 ± 0.07
1.14 ± 0.17
0.231
Th17
d0
2.80 ± 0.26
2.65 ± 0.36
0.424
d2
2.56 ± 0.30
3.01 ± 0.38
0.374
d7
1.08 ± 0.10
1.45 ± 0.15
0.047
Treg
d0
5.44 ± 0.26
6.62 ± 0.45
0.372
d2
7.42 ± 0.60
6.43 ± 0.46
0.194
d7
4.51 ± 0.56
6.19 ± 0.80
0.003
Th1/Th2 ratio
d0
8.63 ± 1.76
7.62 ± 1.32
0.688
d2
9.67 ± 1.94
7.40 ± 1.26
0.253
d7
14.64 ± 0.56
6.03 ± 0.83
< 0.001
Table 4 Comparison of interferon-γ, interleukin-4, interleukin-17, FoxP3 mRNA levels and interferon-γ/interleukin-4 mRNA ratio between G + E and G groups
Variables
G + E group (×105)
G group (×105)
P
IFN-γ
d0
21.84 ± 2.99
16.49 ± 0.84
0.585
d2
50.91 ± 1.46
62.87 ± 2.71
0.096
d7
41.05 ± 1.05
29.36 ± 0.73
0.029
IL-4
d0
47.12 ± 28.65
59.97 ± 15.17
0.651
d2
66.63 ± 18.45
110.12 ± 24.11
< 0.001
d7
31.80 ± 14.59
58.21 ± 5.74
0.224
IL-17
d0
351.29 ± 55.29
386.64 ± 61.88
0.768
d2
406.68 ± 68.21
677.80 ± 133.07
0.171
d7
226.20 ± 18.37
429.94 ± 11.90
0.042
FoxP3
d0
430.38 ± 48.95
384.52 ± 42.19
0.408
d2
468.85 ± 89.81
432.97 ± 44.45
0.338
d7
248.68 ± 58.71
361.01 ± 46.75
0.109
IFN-γ/IL-4 ratio
d0
0.44 ± 0.03
0.39 ± 0.04
0.883
d2
0.80 ± 0.10
0.58 ± 0.03
0.198
d7
1.14 ± 0.08
0.56 ± 0.01
0.003
Table 5 Plasma interferon-γ, interleukin-4, interleukin-17, interleukin-10, transforming growth factor-β1 concentrations between G + E and G groups
Variables
G + E group (pg/mL)
G group (pg/mL)
P
IFN-γ
d0
7.56 ± 0.44
6.67 ± 0.70
0.653
d2
11.17 ± 0.97
19.94 ± 1.37
0.018
d7
8.67 ± 0.74
5.76 ± 0.53
0.165
IL-4
d0
10.31 ± 1.78
10.53 ± 1.28
0.892
d2
21.11 ± 3.76
36.69 ± 6.97
0.013
d7
13.00 ± 1.88
25.50 ± 2.98
0.065
IL-17
d0
20.26 ± 5.82
18.83 ± 3.95
0.304
d2
27.26 ± 10.30
40.10 ± 10.56
0.239
d7
9.12 ± 1.67
16.66 ± 2.38
0.009
IL-10
d0
3.67 ± 0.35
3.37 ± 0.31
0.528
d2
7.17 ± 0.86
5.97 ± 0.48
0.218
d7
4.09 ± 0.29
5.65 ± 0.72
0.06
TGF-β1
d0
6565 ± 1667
5312 ± 1102
0.539
d2
15680 ± 4254
8375 ± 1395
0.12
d7
7555 ± 1555
10691 ± 2571
0.311
IFN-γ/ IL-4
d0
0.74 ± 0.10
0.65 ± 0.13
0.618
d2
0.67 ± 0.08
0.56 ± 0.05
0.309
d7
1.10 ± 0.14
0.35 ± 0.08
< 0.001
Citation: Zhou D, Gu FM, Gao Q, Li QL, Zhou J, Miao CH. Effects of anesthetic methods on preserving anti-tumor T-helper polarization following hepatectomy. World J Gastroenterol 2012; 18(24): 3089-3098